Cancer Diagnostics – Webinars and Online Events

In this webinar, you’ll hear how one of the largest multiomics observational studies to date has revealed lung cancer biomarkers from the blood plasma proteome. Our expert speakers will discuss how the research sheds new light on early-stage lung cancer diagnostics and clinical outcomes and showcase how multiomics approaches are key for characterizing complex diseases.

Key advances will be highlighted across the field of immuno-oncology. Hear a cross-section of experts discuss their research with a focus on basic research and a broad range of established and novel immunotherapeutics.

Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.

This symposium brings together world-leading experts in cancer research and translational medicine to showcase how nanopore sequencing technology is being utilized to identify novel disease biomarkers.

From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.

The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.

Accessed via mobile, tablet or PC, this free-to-attend inaugural online symposium will provide cancer researchers with a unique opportunity to hear about the advances taking place within omics research, immunology, drug discovery and other notable topics.

Watch this webinar to hear how researchers use scRNA-seq to develop a working model for combinational therapeutics to delay development of ITH and much more.